Mapatumumab - PDFSEARCH.IO - Document Search Engine

Mapatumumab
Results: 5

#	Item
1	An Analytics Approach to Designing Clinical Trials for Cancer Dimitris Bertsimas Sloan School and Operations Research Center, Massachusetts Institute of Technology, Allison O’Hair, Stephen Relyea, and Add to Reading List Source URL: web.mit.edu Language: English - Date: 2013-06-11 10:37:10 Epidemiology Bevacizumab Clinical trial Randomized controlled trial Stomach cancer Chemotherapy Trastuzumab Prostate cancer Mapatumumab Medicine Clinical research Design of experiments
2	FOR IMMEDIATE RELEASE Central European Society for Anticancer Drug Research Announces Start of Enrollment in First Randomized Trial of Pharmacokinetic-Guided Add to Reading List Source URL: www.saladax.com Language: English - Date: 2013-11-14 15:47:10 Alkaloids Benzoates Drug discovery Benzamides Diterpenes Paclitaxel Lung cancer Clinical trial Mapatumumab Chemistry Organic chemistry Pharmacology
3	PDF Document Add to Reading List Source URL: www.mirg.org Language: English - Date: 2010-10-19 13:01:07 Cyclopropanes Organofluorides Chemistry Organic chemistry Cabozantinib Exelixis Mesothelioma Foretinib Mapatumumab Tyrosine kinase inhibitors Medicine Quinolines
4	News Release __________________________________________________________________________________ Media Contacts: Annick Robinson Dominique Quirion Merck Add to Reading List Source URL: www.merck.ca Language: English - Date: 2014-08-21 00:35:32 Treatment of rare lung cancers Mapatumumab Lung cancer Response Evaluation Criteria in Solid Tumors Non-small-cell lung carcinoma
5	Active immunotherapy in patients with progressive disease (PD) after first-line therapy: Racotumomab experience. R. E Gomez , S. Alfonso , E. Santiesteban , E. Neninger , M. Laura Ardigo , A. Maria Vazquez , T. Crombet , Add to Reading List Source URL: www.recombio.com Language: English - Date: 2013-06-07 18:49:34 Eastern Cooperative Oncology Group End point of clinical trials Non-small-cell lung carcinoma Mapatumumab Medicine Lung cancer Oncology

UPDATE